Docosahexaenoic Acid therapy of experimental ischemic stroke. - Wikidata - awgldk - TriplyDB

Docosahexaenoic Acid therapy of experimental ischemic stroke.

Docosahexaenoic Acid therapy of experimental ischemic stroke.

http://www.wikidata.org/entity/Q34567799

about

Mammalian lipoxygenases and their biological relevance Mass spectrometry imaging of biomarker lipids for phagocytosis and signalling during focal cerebral ischaemia Neuroimaging of stroke and ischemia in animal models.N-3 fatty acid rich triglyceride emulsions are neuroprotective after cerebral hypoxic-ischemic injury in neonatal mice Neuroprotectin D1 upregulates Iduna expression and provides protection in cellular uncompensated oxidative stress and in experimental ischemic stroke.Enriched endogenous omega-3 fatty acids in mice protect against global ischemia injury.Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer's disease cellular models.Resolving the negative data publication dilemma in translational stroke research.Recent progress in histochemistry and cell biology.Neurorestorative targets of dietary long-chain omega-3 fatty acids in neurological injury.Docosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats.Method parameters' impact on mortality and variability in rat stroke experiments: a meta-analysis.Acute treatment with docosahexaenoic acid complexed to albumin reduces injury after a permanent focal cerebral ischemia in rats.Docosahexaenoic acid improves behavior and attenuates blood-brain barrier injury induced by focal cerebral ischemia in rats.FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse.NPD1-mediated stereoselective regulation of BIRC3 expression through cREL is decisive for neural cell survival.Enriched Endogenous Omega-3 Polyunsaturated Fatty Acids Protect Cortical Neurons from Experimental Ischemic Injury.Intravenous Treatment with a Long-Chain Omega-3 Lipid Emulsion Provides Neuroprotection in a Murine Model of Ischemic Stroke - A Pilot Study Dietary Omega-3 Fatty Acids Do Not Change Resistance of Rat Brain or Liver Mitochondria to Ca(2+) and/or Prooxidants.Protection against Oxygen-Glucose Deprivation/Reperfusion Injury in Cortical Neurons by Combining Omega-3 Polyunsaturated Acid with Lyciumbarbarum Polysaccharide Docosahexaenoic acid complexed to human albumin in experimental stroke: neuroprotective efficacy with a wide therapeutic window Neuroprotection after cerebral ischemia Lipoxygenase: an emerging target for stroke therapy In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [(18)F]GE-180 and effect of docosahexaenoic acid ER stress and effects of DHA as an ER stress inhibitor.Docosahexaenoic acid confers enduring neuroprotection in experimental stroke.Fatty acid methyl esters and Solutol HS 15 confer neuroprotection after focal and global cerebral ischemia.A specific dietary intervention to restore brain structure and function after ischemic stroke.Role of Antioxidants in Neonatal Hypoxic-Ischemic Brain Injury: New Therapeutic Approaches.Neuroinflammation and proteostasis are modulated by endogenously biosynthesized neuroprotectin D1.Mediator lipidomics in ophthalmology: targets for modulation in inflammation, neuroprotection and nerve regeneration.Supra-Additive Interaction of Docosahexaenoic Acid and Naproxen and Gastric Safety on the Formalin Test in Rats.Lipid mediators of inflammation in neurological injury: shifting the balance toward resolution.Supplementation of omega 3 fatty acids improves oxidative stress in activated BV2 microglial cell line.Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease.Molecular mechanisms of signaling via the docosanoid neuroprotectin D1 for cellular homeostasis and neuroprotection.Embracing Biological and Methodological Variance in a New Approach to Pre-Clinical Stroke Testing.A role for lipids as agents to alleviate stroke damage: the neuroprotective effect of 2-hydroxy arachidonic acid.Purine receptors are required for DHA-mediated neuroprotection against oxygen and glucose deprivation in hippocampal slices.

P2860

Q28249730-ABB42310-AC1B-4AE0-99B0-2AB20E9E31EE Q28397015-AEB3BACA-87D0-4287-B569-8575166EB507 Q30712180-4DCF85E6-571C-46C2-B534-5C04F357C6BC Q31111679-8B6C8F9C-FC35-424A-9CDA-5BDDBAF0F822 Q33721387-B3EECB8F-D3A1-41C2-9A00-522496477AE4 Q33825080-851C6C5B-2662-4DF4-917F-EC8FC8105B84 Q33853865-6C26EECD-3FDB-4766-A692-C2E8A2943414 Q33930564-DBE98976-FF99-428E-A52F-A37D53CBE7BE Q34172616-F5319913-F4A4-4FEC-A413-941654FFD7BE Q34282985-F2CA0AB0-9892-438E-8A2B-9564CC3B8B1D Q34464384-CE4795FE-6AB3-4487-B9CE-E1120E7EFCB3 Q34645508-02BBE229-36F7-4BB3-8E2F-6E87DC48E26D Q35032398-AF0610D3-E69D-4F8E-86E1-1CAA0AE395E9 Q35033401-00D03430-35C1-45EE-8BE1-9F119AE6A222 Q35341972-578DDB0D-D015-42AF-8622-529CFB0451DA Q35744338-058BE123-6ED3-4A00-B1F5-346E8C7BFB4F Q35829878-BEEDBFD1-8371-42FE-A9D4-7CD7865E019D Q35854060-6A9AF5B1-E72F-4E73-B6AD-BF7FA8C2CAB3 Q36208295-7EB4590A-EFDD-4871-9ACF-2D931B7D0DCE Q36210621-F6964F9E-89D9-497B-A1F3-0B3E0E933274 Q36507510-B4EB03C3-0129-41C3-A664-5A59B41612BC Q36517694-6E86D3F8-DD79-4C4C-8734-52E6ADB068DB Q36820955-334ED0D6-EE1B-40DA-8090-8B7C15F4818E Q36913914-0DA4B491-D0C8-4176-AE47-84C21A24315B Q37063225-E7516F91-11D9-4E4F-9A8D-EB23D29047B9 Q37396030-950EBBA8-3BC2-40D5-9ED5-0B72D852B1FB Q37619542-EB5B59E7-8702-488E-9706-DA534FD4DC07 Q37628126-D1FDD35B-9576-445D-A660-2EFD5D70B53E Q37667750-088E6330-8F62-43EA-B45E-933E1D4319DA Q37690680-C327FFAA-F494-46AA-8546-4B2A20A19725 Q38041487-C5EE47F0-44C4-4CB5-88F2-4A544D6997E8 Q38131840-47C18C3E-B5F9-49D9-A056-A72F6C579A5B Q38644187-2BB6C780-C858-4B94-83B4-591FDDAE91DA Q38716995-8876BF0D-D5EB-46EB-A627-4B1A4D0175F2 Q38920687-323589CF-1241-4EC9-80B5-8E8B89371CFB Q38955402-5B9904A3-F957-43FD-B6E2-500314D42F88 Q41173599-D6238FE4-B72E-481B-9DB5-5778B3EF128A Q41908695-8E42D4B9-4F6D-4387-8891-364014073997 Q42175551-9F05803C-E865-41C6-914E-79ACD951F8F7 Q43157386-CF053F2C-EA3B-482F-BD25-4C36946F6E2A

P2860

Docosahexaenoic Acid therapy of experimental ischemic stroke.

http://www.wikidata.org/entity/Q34567799

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Docosahexaenoic Acid therapy of experimental ischemic stroke.

@ast

Docosahexaenoic Acid therapy of experimental ischemic stroke.

@en

Docosahexaenoic Acid therapy of experimental ischemic stroke.

@nl

type

label

Docosahexaenoic Acid therapy of experimental ischemic stroke.

@ast

Docosahexaenoic Acid therapy of experimental ischemic stroke.

@en

Docosahexaenoic Acid therapy of experimental ischemic stroke.

@nl

prefLabel

Docosahexaenoic Acid therapy of experimental ischemic stroke.

@ast

Docosahexaenoic Acid therapy of experimental ischemic stroke.

@en

Docosahexaenoic Acid therapy of experimental ischemic stroke.

@nl

P1433

Q34567799-17E74901-FC63-4117-8E45-ED964D866652

P1476

Q34567799-B9737DF2-1578-414A-AF4C-0E92BCD3FF00

P2093

Q34567799-04D2F573-AEF7-4009-A12C-06A79675E0DD

Q34567799-07CAFD7B-F426-4511-B088-2D55A49AE378

Q34567799-1CA24301-FC26-404E-921A-27157F0DE5EC

Q34567799-7F8E64ED-1B3A-4ED2-A1D3-CA6D10571026

Q34567799-96057554-4843-465F-A809-989EDB8A5265

Q34567799-AC45ED8F-AF6B-4415-91C8-D723671F590D

Q34567799-D8CADFF1-4A50-4879-83EE-7571106A8900

Q34567799-E556EECD-232C-4BBF-BEC1-791563114217

P2860

Q34567799-02FDE404-71F6-43DE-A45F-FF0A49B57DF4

Q34567799-085DEE31-CD3C-4B27-BC62-CF7558467BC5

Q34567799-0F78F904-FFF5-4E73-BADB-05884BB134AB

Q34567799-19FD1FD2-876A-4FCA-9EAD-035127321476

Q34567799-2BB32322-776D-4FB6-BBBC-3973408C9997

Q34567799-388449C2-08A4-494B-98D0-B56E258120AB

Q34567799-4832CC63-162D-4F81-93C9-CC2FA9C40F75

Q34567799-49A3709B-FB9D-45BB-BB79-CE6E1FCB0729

Q34567799-4BCF213D-0174-49D4-99DD-EB770693C734

Q34567799-5577CC9C-9298-49C3-8261-BC882851698D

P2888

Q34567799-AA6BBAC0-8516-49F2-A82E-105CFD94F46A

P304

Q34567799-56D642BD-88FE-4C6D-A2E0-A6D34939DA1F

P31

Q34567799-B3457EC1-0737-4A9C-B8AD-5D0AA980E834

P356

Q34567799-B326C667-77CE-43F6-96CD-5D645A0AC32D

P433

Q34567799-D5E22CBF-A41B-433D-8CD1-E332404CB6BB

P478

Q34567799-AEBF635B-D94B-42C6-B697-5F3FB68BE555

P577

Q34567799-11005167-1374-4E25-B71D-2A44CD6E5B9D

P5875

Q34567799-58E3ED6E-7CFC-4DB5-B6C1-C5D1188600EF

P6179

Q34567799-872F7B62-0B07-46E4-889C-43211FC223BB

P698

Q34567799-DAFBE033-6A72-4FCC-8CBE-C77B4097C1DF

P932

Q34567799-DEBBE9B3-3011-41EA-BF90-611330A29770

P356

S12975-010-0046-0

P1433

Translational stroke research

P1476

Docosahexaenoic Acid therapy of experimental ischemic stroke.

@en

P2093

Andre Obenaus

http://www.w3.org/2001/XMLSchema#string

Kristal D Atkins

http://www.w3.org/2001/XMLSchema#string

Larissa Khoutorova

http://www.w3.org/2001/XMLSchema#string

Ludmila Belayev

http://www.w3.org/2001/XMLSchema#string

Nicolas G Bazan

http://www.w3.org/2001/XMLSchema#string

Song Hong

http://www.w3.org/2001/XMLSchema#string

Tiffany N Eady

http://www.w3.org/2001/XMLSchema#string

Yan Lu

http://www.w3.org/2001/XMLSchema#string

P2860

A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

Targeting ischemic penumbra Part I: from pathophysiology to therapeutic strategy

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases

Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival

Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1.

Biomaterial design strategies for the treatment of spinal cord injuries.

The science of stroke: mechanisms in search of treatments.

A new penumbra: transitioning from injury into repair after stroke.

P2888

s12975-010-0046-0

P304

33-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12975-010-0046-0

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50596845

http://www.w3.org/2001/XMLSchema#string

P6179

1018773927

http://www.w3.org/2001/XMLSchema#string

P698

21423332

http://www.w3.org/2001/XMLSchema#string

P932

3037476

http://www.w3.org/2001/XMLSchema#string